OmnipodĀ® for HCPs
@omnipod_system_for_hcps
Acton, Massachusettshttps://www.omnipod.com/hcp Medical Equipment ManufacturingOverview
About OmnipodĀ® for HCPs
Developed by Insulet Corporation, Omnipod 5 helps people navigate the constant complexities of both type 1 and type 2 diabetes. It is the first tubeless and waterproof* automated insulin delivery system in the US, in the form of a small, wearable Pod that integrates with the leading continuous glucose monitor sensor brands. The system provides personalized, automated insulin delivery without tubing, fingersticks, or multiple daily injectionsā , so people can spend less time thinking about diabetes and more time living their lives. Omnipod 5 real-world evidence demonstrated over 80% time in range with optimized settingsĀ¹.
This account is intended for a US healthcare professional audience.
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The remote handheld Controller is not waterproof.
ā Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings
Omnipod 5 is indicated for people with type 1 diabetes, ages 2 years and older and type 2 diabetes in persons 18 years of age and older. Rx only. WARNING: Do not use SmartAdjustā¢ technology for people under the age of 2 or who require less than 5 U of insulin per day. Please see Omnipod.com/safety for important safety information.
1. Retrospective RWE data on file. 2025. Results shown for users with optimized settings including sufficient CGM data (ā„75% of days with ā„220 readings), ā„90% time in Automated Mode, ā„5 bolus/day and an average Target Glucose of 110-115 mg/dL. Optimized settings: ISF x TDI ā¤1500, I:C Ratio x TDI ā¤350. RF-062025-00014.
This account is intended for a US healthcare professional audience.
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The remote handheld Controller is not waterproof.
ā Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings
Omnipod 5 is indicated for people with type 1 diabetes, ages 2 years and older and type 2 diabetes in persons 18 years of age and older. Rx only. WARNING: Do not use SmartAdjustā¢ technology for people under the age of 2 or who require less than 5 U of insulin per day. Please see Omnipod.com/safety for important safety information.
1. Retrospective RWE data on file. 2025. Results shown for users with optimized settings including sufficient CGM data (ā„75% of days with ā„220 readings), ā„90% time in Automated Mode, ā„5 bolus/day and an average Target Glucose of 110-115 mg/dL. Optimized settings: ISF x TDI ā¤1500, I:C Ratio x TDI ā¤350. RF-062025-00014.